New Lenses Approved for Cataract Patients

The FDA has approved Abbott's Tecnis Symfony Intraocular Lenses for the treatment of cataracts.

The FDA has approved Abbott’s Tecnis Symfony Intraocular Lenses for the treatment of cataracts.

Tecnis Symfony are the only approved lenses with a full range of continuous, high-quality vision following cataract surgery and which also mitigate the effects of presbyopia.

For patients with astigmatism, the Tecnis Symfony Toric IOL will also be available.

“Abbott is focused on improving people’s vision and their lives by helping them stay healthy and active,” said Thomas Frinzi, senior vice president of Abbott’s vision business, in a press release. “Symfony offers patients, including those with astigmatism, an option for crisp, clear vision at all distances.”

During cataract surgery, an intraocular lens is inserted into the eye. Typically, a monofocal lens is used, but it only allows an individual to see at a distance. The Tecnis Symfony lens is designed to improve both range and quality of vision.

In clinical trials, serious adverse reactions related to the Tecnis Symfony lenses were not related to the product itself. However, patients with pre-existing medical conditions have a higher risk of experiencing complications after cataract surgery.

More than half of all Americans will have a cataract or have had cataract surgery by age 80.